These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 696)

  • 21. [Dose-response relationship of beta-adrenergic blocking agents].
    Seyberth H
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1663-5. PubMed ID: 4150008
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.
    Aström H; Vallin H
    Br Heart J; 1974 Dec; 36(12):1194-1200. PubMed ID: 4155316
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacology of the optically active isomers of talinolol (cordanum) 2].
    Femmer K; Poppe H
    Pharmazie; 1982 Jul; 37(7):505-8. PubMed ID: 6127726
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemodynamic effects of labetalol in the dog. Comparative study in the anesthetized open-chest dog and in the conscious dog.
    Saito D; Abe Y; Tani H; Kusachi S; Takeda K; Hyodo T; Haraoka S; Nagashima H
    Arzneimittelforschung; 1986; 36(1):88-91. PubMed ID: 2869764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of alpha and beta blockers on hemodynamics of SHR.
    Numao Y; Iriuchijima J
    Jpn Heart J; 1974 Mar; 15(2):166-72. PubMed ID: 4152042
    [No Abstract]   [Full Text] [Related]  

  • 26. [The pharmacology of (+/-)-1-(4-cyclohexylureido-phenoxy)-2-hydroxy-3-tert-butylaminopropane (Talinolol, Cordanum, 02-115)].
    Femmer K; Bartsch R; Leonhardt U; von Littrow C; Riedel H
    Pharmazie; 1975 Oct; 30(10):642-51. PubMed ID: 688
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemodynamic effects of intravenous injection of beta-adrenergic inhibitor (Pindolol) in man].
    Scebat L; Rocha P; Ourbak P; Renais J; Lenègre J
    G Ital Cardiol; 1972; 2(5):626-35. PubMed ID: 4404052
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemodynamic effects of nitrate derivatives (trinitrine and isosorbide dinitrate)].
    Baligadoo S; Chiche P
    Coeur Med Interne; 1979; 18(2):271-82. PubMed ID: 114352
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
    Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon.
    Lertora JJ; Mark AL; Johannsen J; Wilson WR; Abboud FM
    J Clin Invest; 1975 Sep; 56(3):719-24. PubMed ID: 239966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract]   [Full Text] [Related]  

  • 33. Specific beta adrenergic blockade by practolol.
    Thompson ME; McDonald RH; Leon DF; Shaver JA
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 1):750-60. PubMed ID: 4154153
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiovascular effects of bucindolol (MJ 13105) in conscious dogs.
    Deitchman D; Byrne JE; Snyder RW
    Arch Int Pharmacodyn Ther; 1980 Sep; 247(1):76-88. PubMed ID: 6108746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic and renal hemodynamic effects of a new alpha-adrenergic blocking agent: NC 7197.
    Lohmöller RM; Lohmöller GJ; Frohlich ED
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):170-80. PubMed ID: 4147750
    [No Abstract]   [Full Text] [Related]  

  • 36. Adrenoceptor blockade of the circulatory responses to intravenous isoproterenol.
    Richards DA; Prichard BN; Dobbs RJ
    Clin Pharmacol Ther; 1978 Sep; 24(3):264-73. PubMed ID: 28869
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system.
    Schmidt BM; Georgens AC; Martin N; Tillmann HC; Feuring M; Christ M; Wehling M
    J Clin Endocrinol Metab; 2001 Feb; 86(2):761-7. PubMed ID: 11158043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in man.
    Hillis WS; Hutton I; Lawrie TD; Lorimer AR; Reid JM
    Br J Pharmacol; 1974 May; 51(1):15-9. PubMed ID: 4155334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.
    Aronow WS; March H; Vangrow JS; Cassidy J; Kern JC; Khemka M; Vawter M; Pagano J
    Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
    Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
    J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.